Major cardiac concerns in therapy and vaccinations for COVID-19

Syam Sundar Junapudi; Sunil Junapudi; Kishore Ega; Bojjibabu Chidipi

doi:10.1016/j.metop.2021.100102

Major cardiac concerns in therapy and vaccinations for COVID-19

Metabol Open. 2021 Sep:11:100102. doi: 10.1016/j.metop.2021.100102. Epub 2021 Jun 29.

Authors

Syam Sundar Junapudi¹, Sunil Junapudi², Kishore Ega³, Bojjibabu Chidipi⁴

Affiliations

¹ Department of Community Medicine, Govt Medical College Suryapet, Suryapet District, Telangana, 508213, India.
² Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cherryal, Keesara, Medchalmalkajgiri District, Telangana, 501301, India.
³ Department of Pediatrics, Narayana Medical College, Nellore, Andhra Pradesh-524002, India.
⁴ Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL,33612, USA.

Abstract

The necessity and impact of SARS-CoV-2 on the world's health have led to the development and production of practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. In this review, we discussed the cardiovascular alteration in SARS-CoV-2 treatment, and we also reviewed the vaccination information and studies that have been done to primary considerations for cardiac patients.

Keywords: COVID-19; Cardiac patients; SARS-CoV-2; Vaccine.